Risk assessment in heart failure (HF) is very challenging, encompassing many data, like NYHA class, clinical history, comorbidities, clinical test parameters, biochemical markers, adherence, and tolerance to guideline-recommended drugs. , Risk assessment is critical in advanced HF to support the decision to provide the most adequate therapy for a given patient, from heart transplantation to long-duration LVAD or palliative care. – […]